Results 1 - 20 of 47,029 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Show only
- Peer-reviewed Journals (38,024)
Refined by:
subject:
Infections
| Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
|---|---|---|---|
| 1 |
Material Type: Article
|
|
Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 VariantNew England Journal of Medicine, 2021-05, Vol.384 (20), p.1885-1898 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2102214 ;PMID: 33725432Digital Resources/Online E-Resources |
| 2 |
Material Type: Article
|
|
SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impactNature reviews. Immunology, 2022-01, Vol.22 (1), p.57-65 [Peer Reviewed Journal]2021. Springer Nature Limited. ;COPYRIGHT 2022 Nature Publishing Group ;Springer Nature Limited 2021. ;Springer Nature Limited 2021 ;ISSN: 1474-1733 ;EISSN: 1474-1741 ;DOI: 10.1038/s41577-021-00662-4 ;PMID: 34876702Full text available |
| 3 |
Material Type: Article
|
|
Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infectionNature medicine, 2021-11, Vol.27 (11), p.2032-2040 [Peer Reviewed Journal]2021. The Author(s). ;COPYRIGHT 2021 Nature Publishing Group ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-021-01540-1 ;PMID: 34588689Full text available |
| 4 |
Material Type: Article
|
|
Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trialThe Lancet (British edition), 2022-01, Vol.399 (10321), p.237-248 [Peer Reviewed Journal]2022 Elsevier Ltd ;Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;2021 Elsevier Ltd. All rights reserved. 2022 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)02753-7 ;PMID: 34953526Full text available |
| 5 |
Material Type: Article
|
|
A pooled testing strategy for identifying SARS-CoV-2 at low prevalenceNature (London), 2021-01, Vol.589 (7841), p.276-280 [Peer Reviewed Journal]COPYRIGHT 2021 Nature Publishing Group ;Copyright Nature Publishing Group Jan 14, 2021 ;ISSN: 0028-0836 ;ISSN: 1476-4687 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-020-2885-5 ;PMID: 33086375Full text available |
| 6 |
Material Type: Article
|
|
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19New England Journal of Medicine, 2021-06, Vol.384 (23), p.2187-2201 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2101544 ;PMID: 33882225Digital Resources/Online E-Resources |
| 7 |
Material Type: Article
|
|
Dynamic Public Health Surveillance to Track and Mitigate the US COVID-19 Epidemic: Longitudinal Trend Analysis StudyJournal of medical Internet research, 2020-12, Vol.22 (12), p.e24286-e24286 [Peer Reviewed Journal]Lori Ann Post, Tariq Ziad Issa, Michael J Boctor, Charles B Moss, Robert L Murphy, Michael G Ison, Chad J Achenbach, Danielle Resnick, Lauren Nadya Singh, Janine White, Joshua Marco Mitchell Faber, Kasen Culler, Cynthia A Brandt, James Francis Oehmke. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 03.12.2020. ;Copyright Gunther Eysenbach MD MPH, Associate Professor Dec 2020 ;Lori Ann Post, Tariq Ziad Issa, Michael J Boctor, Charles B Moss, Robert L Murphy, Michael G Ison, Chad J Achenbach, Danielle Resnick, Lauren Nadya Singh, Janine White, Joshua Marco Mitchell Faber, Kasen Culler, Cynthia A Brandt, James Francis Oehmke. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 03.12.2020. 2020 ;ISSN: 1438-8871 ;ISSN: 1439-4456 ;EISSN: 1438-8871 ;DOI: 10.2196/24286 ;PMID: 33216726Full text available |
| 8 |
Material Type: Article
|
|
Considerations in boosting COVID-19 vaccine immune responsesThe Lancet (British edition), 2021-10, Vol.398 (10308), p.1377-1380 [Peer Reviewed Journal]2021 World Health Organization. Published by Elsevier Ltd/Inc/BV. All rights reserved. ;2021. World Health Organization. Published by Elsevier Ltd/Inc/BV. All rights reserved. ;Distributed under a Creative Commons Attribution 4.0 International License ;2021 World Health Organization. Published by Elsevier Ltd/Inc/BV. All rights reserved. 2021 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)02046-8 ;PMID: 34534516Full text available |
| 9 |
Material Type: Article
|
|
Seasonal coronavirus protective immunity is short-lastingNature medicine, 2020-11, Vol.26 (11), p.1691-1693 [Peer Reviewed Journal]COPYRIGHT 2020 Nature Publishing Group ;The Author(s), under exclusive licence to Springer Nature America, Inc. 2020. ;ISSN: 1078-8956 ;ISSN: 1546-170X ;EISSN: 1546-170X ;DOI: 10.1038/s41591-020-1083-1 ;PMID: 32929268Full text available |
| 10 |
Material Type: Article
|
|
Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous InfectionNew England Journal of Medicine, 2022-03, Vol.386 (13), p.1207-1220 [Peer Reviewed Journal]Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;COPYRIGHT 2022 Massachusetts Medical Society ;2022. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2022 Massachusetts Medical Society. All rights reserved. 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2118691 ;PMID: 35172051Digital Resources/Online E-Resources |
| 11 |
Material Type: Article
|
|
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational studyThe lancet oncology, 2021-06, Vol.22 (6), p.765-778 [Peer Reviewed Journal]2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2021. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2021 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(21)00213-8 ;PMID: 33930323Full text available |
| 12 |
Material Type: Article
|
|
How bad is Omicron? What scientists know so farNature (London), 2021-12, Vol.600 (7888), p.197-199 [Peer Reviewed Journal]Copyright Nature Publishing Group Dec 9, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/d41586-021-03614-z ;PMID: 34857948Full text available |
| 13 |
Material Type: Article
|
|
Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort studyThe Lancet infectious diseases, 2021-11, Vol.21 (11), p.1529-1538 [Peer Reviewed Journal]2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license ;Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2021. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. This work is published under http://creativecommons.org/licenses/by-nc-nd/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license 2021 ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(21)00289-9 ;PMID: 34174193Full text available |
| 14 |
Material Type: Article
|
|
Diagnostics for COVID-19: moving from pandemic response to controlThe Lancet (British edition), 2022-02, Vol.399 (10326), p.757-768 [Peer Reviewed Journal]2022 Elsevier Ltd ;Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;2021 Elsevier Ltd. All rights reserved. 2022 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)02346-1 ;PMID: 34942102Full text available |
| 15 |
Material Type: Article
|
|
Rapid coronavirus tests: a guide for the perplexedNature (London), 2021-02, Vol.590 (7845), p.202-205 [Peer Reviewed Journal]COPYRIGHT 2021 Nature Publishing Group ;Copyright Nature Publishing Group Feb 11, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/d41586-021-00332-4 ;PMID: 33564189Full text available |
| 16 |
Material Type: Article
|
|
COVID-19 vaccines for patients with cancer: benefits likely outweigh risksJournal of hematology and oncology, 2021-02, Vol.14 (1), p.38-11, Article 38 [Peer Reviewed Journal]COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1756-8722 ;EISSN: 1756-8722 ;DOI: 10.1186/s13045-021-01046-w ;PMID: 33640005Full text available |
| 17 |
Material Type: Article
|
|
Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineNew England Journal of Medicine, 2020-12, Vol.383 (27), p.2603-2615 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;COPYRIGHT 2020 Massachusetts Medical Society ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2020 Massachusetts Medical Society. All rights reserved. 2020 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2034577 ;PMID: 33301246Digital Resources/Online E-Resources |
| 18 |
Material Type: Article
|
|
Effectiveness of BNT162b2 and ChAdOx1 nCoV-19 COVID-19 vaccination at preventing hospitalisations in people aged at least 80 years: a test-negative, case-control studyThe Lancet infectious diseases, 2021-11, Vol.21 (11), p.1539-1548 [Peer Reviewed Journal]2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;2021 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(21)00330-3 ;PMID: 34174190Full text available |
| 19 |
Material Type: Article
|
|
Safety and Efficacy of NVX-CoV2373 Covid-19 VaccineNew England Journal of Medicine, 2021-09, Vol.385 (13), p.1172-1183 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2107659 ;PMID: 34192426Digital Resources/Online E-Resources |
| 20 |
Material Type: Article
|
|
Advancements in detection of SARS-CoV-2 infection for confronting COVID-19 pandemicsLaboratory investigation, 2022-01, Vol.102 (1), p.4-13 [Peer Reviewed Journal]2021 United States & Canadian Academy of Pathology ;2021. The Author(s), under exclusive licence to United States and Canadian Academy of Pathology. ;The Author(s), under exclusive licence to United States and Canadian Academy of Pathology 2021. ;The Author(s), under exclusive licence to United States and Canadian Academy of Pathology 2021 ;ISSN: 0023-6837 ;EISSN: 1530-0307 ;DOI: 10.1038/s41374-021-00663-w ;PMID: 34497366Full text available |
Results 1 - 20 of 47,029 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Personalize your results
Refine Search Results
Expand My Results
Show only
- Peer-reviewed Journals (38,024)
Refine My Results
Creation Date
- Before 2013 (2)
- 2013 To 2017 (2)
- 2018 To 2019 (3)
- 2020 To 2022 (36,362)
- After 2022 (10,661)
-
More options
New Records
- New From Last Month (180)
- New From Last 3 Month (892)
-
More options
Resource Type
- Articles (42,443)
- Newspaper Articles (3,458)
- magazinearticle (883)
- Text Resources (140)
- Reports (66)
- Conference Proceedings (17)
- Newsletter Articles (11)
- Reviews (4)
- Videos (3)
- Books (2)
- Web Resources (2)
-
More options
Subject
- Covid-19 (42,399)
- Coronaviruses (38,502)
- Science & Technology (33,881)
- Severe Acute Respiratory Syndrome Coronavirus 2 (30,203)
- Life Sciences & Biomedicine (29,989)
- Pandemics (24,424)
- Humans (16,359)
- Disease Transmission (16,308)
- Sars-Cov-2 (15,058)
- Patients (12,107)
- Covid-19 Vaccines (11,239)
- Viral Diseases (10,298)
- Public Health (9,316)
- Viruses (8,770)
- Epidemics (8,690)
- Infectious Diseases (7,515)
- Health Aspects (7,205)
- Vaccines (6,815)
- General & Internal Medicine (6,662)
-
More options
Databases
- ProQuest Central (45,318)
- Coronavirus Research Database (28,499)
- DOAJ Directory of Open Access Journals (28,199)
- PubMed Central (28,123)
- ROAD: Directory of Open Access Scholarly Resources (24,334)
- GFMER Free Medical Journals (17,856)
- MEDLINE (16,707)
- Springer Nature OA/Free Journals (4,450)
- HighWire Press (Free Journals) (3,349)
- ProQuest One Psychology (2,884)
- Public Library of Science (PLoS) (2,090)
- Wiley-Blackwell Open Access Titles (2,029)
- Nature Open Access (1,301)
- BMJ Open Access Journals (1,245)
- Journals@Ovid Open Access Journal Collection Rolling (935)
- Taylor & Francis Open Access (634)
- U.S. Government Documents (586)
- Centers for Disease Control and Prevention (542)
- Cambridge Wholly Gold Open Access Journals (502)
- Hyper Article en Ligne (HAL) (Open Access) (496)
-
More options
Language
Journal Title
- Curēus (1,246)
- International Journal Of Environmental Research And Public Health (1,462)
- International Journal Of Molecular Sciences (670)
- Journal Of Clinical Medicine (925)
- New York Times (1,631)
- Plos One (1,686)
- Reactions Weekly (720)
- The Washington Post (1,553)
- Vaccines (1,536)
- Viruses (1,218)
-
More options
|
||||
 |
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY |  |
(84-028) 37 755 057 | Feedback |
| 19 Nguyen Huu Tho St. Dist.7, HCM |  |
thuvien@tdtu.edu.vn | ||